持股变动声明
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069567 Size: 14 KB 网页链接
简介:Neuronetics, Inc.于2003年4月在特拉华州注册成立。该公司是一家商业阶段的医疗技术公司,专注于设计,开发和销售可改善患有精神疾病患者生活质量的产品。 该公司的第一个商业产品NeuroStar先进治疗系统是一种非侵入性,非系统性的基于办公室的治疗方法,它使用经颅磁刺激或TMS创建脉冲MRI强度磁场,诱导电流设计为刺激与情绪相关的大脑特定区域。美国食品和药物管理局或FDA批准该系统治疗成人患有重度抑郁症或MDD的患者,这些患者在目前的MDD发作中未能从以前的抗抑郁药物中获得满意的改善。
今开:1.99 | 昨收:2 |
最高:2.0399 | 最低:1.94 |
涨停价: | 跌停价: |
总市值:59995126 |
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069567 Size: 14 KB 网页链接
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069576 Size: 15 KB 网页链接
Neuronetics(STIM)06-06 18:15
$Neuronetics(STIM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-155511 Act: 34 Size: 6 MB 网页链接
Neuronetics(STIM)06-07 05:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069983 Size: 4 KB 网页链接
Neuronetics(STIM)06-04 04:05
$Neuronetics(STIM)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-153005 Act: 34 Size: 150 KB 网页链接
Neuronetics(STIM)05-08 04:35
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-007073 Act: 34 Size: 7 MB 网页链接
Neuronetics(STIM)07-17 03:55
$Neuronetics(STIM)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-004940 Act: 33 Size: 4 KB 网页链接
Neuronetics(STIM)06-06 08:25
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069573 Size: 15 KB 网页链接
Neuronetics(STIM)05-07 19:35
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-24-006909 Act: 34 Size: 454 KB 网页链接
Neuronetics(STIM)05-07 19:35
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001558370-24-006907 Act: 34 Size: 149 KB 网页链接
美股律师郝俊波2021-10-15 13:53
$Neuronetics(STIM)$
【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
美股短线交易员2020-07-15 22:17
哈密瓜咬一口2018-07-06 16:50
$Neuronetics, Inc.(STIM)$ 开发设计销售改善精神疾病的产品的公司,发行价17查看全文
$Neuronetics(STIM)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-004971 Act: 33 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-004940 Act: 33 Size: 4 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001777141-24-000009 Act: 34 Size: 93 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069983 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-155511 Act: 34 Size: 6 MB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069564 Size: 15 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069573 Size: 15 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069576 Size: 15 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069567 Size: 14 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-153005 Act: 34 Size: 150 KB 网页链接